Contract with Customer, Liability, Current in CNY of NovaBridge Biosciences from Q4 2018 to Q4 2023

Taxonomy & unit: us-gaap: CNY and USD
Description: Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary: NovaBridge Biosciences quarterly Contract with Customer, Liability, Current history and change rate from Q4 2018 to Q4 2023.
NovaBridge Biosciences Contract with Customer, Liability, Current for the quarter ending 31 Dec 2023 was ¥2,200,000, a 75% decline year-over-year.
Source SEC data: View on sec.gov

Contract with Customer, Liability, Current, Quarterly (CNY)

Contract with Customer, Liability, Current, YoY Quarterly Change (%)

NovaBridge Biosciences Quarterly Contract with Customer, Liability, Current (CNY)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2023	¥2,200,000	-¥6,477,000	-75%	31 Dec 2023	20-F	30 Apr 2024	2023	FY
Q4 2022	¥8,677,000			31 Dec 2022	20-F	30 Apr 2024	2023	FY
Q4 2018	¥14,151,000			31 Dec 2018	20-F	29 Apr 2020	2019	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.